Literature DB >> 36273057

Risk Factors and In-Hospital Outcomes of Perioperative Atrial Fibrillation for Patients with Cancer: A Meta-Analysis.

Keiko Inoue1, Kazuko Tajiri2,3, DongZhu Xu1, Nobuyuki Murakoshi1, Masaki Ieda1.   

Abstract

BACKGROUND: Perioperative atrial fibrillation is a common postoperative complication. Adverse consequences associated with POAF include hemodynamic instability, increased risk of stroke, extended hospital stays, and increased mortality.
METHODS: To determine the risk factors for POAF and to investigate the outcomes of POAF for patients with cancer, a systematic search of the PubMed and Cochrane Library databases was conducted from inception of the study to 1 September 2021. The inclusion criteria specified studies reporting the prevalence of POAF among patients with cancer. The study excluded articles not written in English, review articles, case reports, letters, commentaries, systematic reviews, meta-analyses, and conference abstracts.
RESULTS: The search identified 49 studies with 201,081 patients, and the pooled prevalence of POAF was 13.5% (95% confidence interval [CI], 11.6-15.7%). Meta-analyses showed that the incidence of POAF among patients with cancer was associated with age (mean difference [MD], 4.31; 95%CI, 3.16-5.47), male sex (odds ratio [OR], 1.39; 95% CI, 1.19-1.62), chronic obstructive pulmonary disease (OR, 2.47; 95% CI, 1.71-3.56), hypertension (OR, 1.47; 95% CI, 1.23-1.75), intraoperative blood transfusion (OR, 4.58; 95% CI, 2.31-9.10), and open surgery (OR, 1.51; 95% CI, 1.26-1.81). Patients with POAF had significantly higher in-hospital mortality (OR, 4.25; 95% CI, 2.79-6.45), longer hospital stays (MD, 3.07; 95% CI, 1.63-4.51), and higher incidences of pneumonia (OR, 3.32; 95% CI, 2.85-3.86), stroke (OR, 6.57; 95% CI, 1.56-26.00), and myocardial infarction (OR, 3.00; 95% CI, 1.45-6.20) than those without POAF.
CONCLUSIONS: For patients with cancer, POAF is associated with an increased burden of comorbidities and worse outcomes.
© 2022. Society of Surgical Oncology.

Entities:  

Year:  2022        PMID: 36273057     DOI: 10.1245/s10434-022-12690-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   4.339


  58 in total

1.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

2.  Perioperative atrial fibrillation and the long-term risk of ischemic stroke.

Authors:  Gino Gialdini; Katherine Nearing; Prashant D Bhave; Ubaldo Bonuccelli; Costantino Iadecola; Jeff S Healey; Hooman Kamel
Journal:  JAMA       Date:  2014-08-13       Impact factor: 56.272

3.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

4.  The incidence and predictors of postoperative atrial fibrillation after noncardiothoracic surgery.

Authors:  Gwan Hyeop Sohn; Dae-Hee Shin; Kyung Min Byun; Hye Jin Han; Soo Jin Cho; Young Bin Song; Jun Hyung Kim; Young Keun On; June Soo Kim
Journal:  Korean Circ J       Date:  2009-03-25       Impact factor: 3.243

5.  Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery.

Authors:  Prashant D Bhave; L Elizabeth Goldman; Eric Vittinghoff; Judith Maselli; Andrew Auerbach
Journal:  Am Heart J       Date:  2012-10-26       Impact factor: 4.749

Review 6.  Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review.

Authors:  Orly Leiva; Duaa AbdelHameid; Jean M Connors; Christopher P Cannon; Deepak L Bhatt
Journal:  JACC CardioOncol       Date:  2021-11-16

Review 7.  Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-30       Impact factor: 32.419

8.  Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study.

Authors:  Steven A Lubitz; Xiaoyan Yin; Michiel Rienstra; Renate B Schnabel; Allan J Walkey; Jared W Magnani; Faisal Rahman; David D McManus; Thomas M Tadros; Daniel Levy; Ramachandran S Vasan; Martin G Larson; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2015-03-13       Impact factor: 29.690

Review 9.  Atrial fibrillation.

Authors:  Thomas M Munger; Li-Qun Wu; Win K Shen
Journal:  J Biomed Res       Date:  2013-12-28

10.  The 2 years' long-term efficacy and safety of peroral endoscopic myotomy for the treatment of achalasia: a systematic review.

Authors:  Huan Li; Wei Peng; Shu Huang; Yutang Ren; Yan Peng; Qing Li; Jiao Wu; Xiangsheng Fu; Xiaowei Tang
Journal:  J Cardiothorac Surg       Date:  2019-01-03       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.